Phase I/II dose-ranging, randomized clinical trial of recombinant human nerve growth factor in the treatment of neurotrophic keratitis: Preliminary results
31/03/2014
Autori: Sinigaglia F. et al.
Pubblicato in:
Investigative Ophthalmology and Visual Science